SCY-635

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2014
01220102014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
282 17 APRIL 2015 • VOL 348 ISSUE 6232 sciencemag.org SCIENCE A lthough hundreds of viruses are known to cause human disease… (More)
Is this relevant?
2014
2014
BACKGROUND & AIMS Cyclophilin inhibitors are being developed for treatment of hepatitis C virus (HCV) infection. They are… (More)
Is this relevant?
Review
2014
Review
2014
The cyclophilins are widely expressed enzymes that catalyze the interconversion of the cis and trans peptide bonds of prolines… (More)
Is this relevant?
2013
2013
BACKGROUND & AIMS Cyclophilin A (CypA) is vital for HCV replication. Cyp inhibitors successfully decrease viral loads in HCV… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
The nonimmunosuppressive cyclophilin (Cyp) inhibitor SCY-635 blocks hepatitis C virus (HCV) replication both in vitro and in vivo… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
BACKGROUND & AIMS SCY-635 is a non-immunosuppressive analog of cyclosporin A that inhibits cyclophilins A and B and hepatitis C… (More)
  • table 2
  • table 1
  • figure 1
  • table 3
  • table 4
Is this relevant?
2010
2010
SCY-635 is a novel nonimmunosuppressive cyclosporine-based analog that exhibits potent suppression of hepatitis C virus (HCV… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?